Addiction

RECOVERY CENTERS OF AMERICA, LAW FIRM OBERMAYER REBMANN MAXWELL & HIPPEL, AND THE HYER CALLING FOUNDATION ANNOUNCE INAUGURAL EVENT ADVOCATING FOR LEGAL RECOVERY COMMUNITY

Retrieved on: 
Tuesday, April 9, 2024
Well, CLE, Employment, Partnership, Patient, Lawyer, Senior counsel, Insurance, Life, HCF, Addiction, Workplace, Alumni association, Obermayer, RCA, Nursing

King of Prussia, PA, April 09, 2024 (GLOBE NEWSWIRE) -- PHILADELPHIA, PA -- Recovery Centers of America ( www.RecoveryCentersofAmerica.com ), together with The Hyer Calling Foundation, ( www.hyercalling.org ) announce their inaugural event advocating for the legal recovery community on May 8 at 2pm at RCA’s Devon location.

Key Points: 
  • King of Prussia, PA, April 09, 2024 (GLOBE NEWSWIRE) -- PHILADELPHIA, PA -- Recovery Centers of America ( www.RecoveryCentersofAmerica.com ), together with The Hyer Calling Foundation, ( www.hyercalling.org ) announce their inaugural event advocating for the legal recovery community on May 8 at 2pm at RCA’s Devon location.
  • The event is specifically scheduled for the middle of Lawyer Well Being Week.
  • As the gold standard in SUD treatment and co-occurring mental health conditions, RCA has always had a robust Alumni Association providing former patients in recovery an ongoing support system.
  • For media inquiries or interviews please contact Nina Zucker Associates at 610.457.4387 or [email protected] , Maureen Keown at 610.496.6290 or [email protected] or Dineo Thompson at [email protected] at 215.

Clearmind Medicine CEO Issues Letter to Shareholders

Retrieved on: 
Tuesday, April 9, 2024
Data monitoring committee, Depression, Obesity, Mevalonate pathway, Psychiatry, Dyskinesia, Addiction, Safety, Binge drinking, Data, DSM-IV codes, Research, MEAI, Clinical trial, Johns Hopkins University, Phase, Patent, Therapy, Ministry, FDA, Impulsivity, CTS, IRB, Pharmaceutical industry

Recently, our efforts reached a key inflection point as the Israeli Ministry of Health approved our Phase I/IIa clinical trial for CMND-100 for AUD.

Key Points: 
  • Recently, our efforts reached a key inflection point as the Israeli Ministry of Health approved our Phase I/IIa clinical trial for CMND-100 for AUD.
  • CMND-100, a pioneering MEAI-based (5-methoxy-2-aminoindane) formula, has exhibited encouraging results in pre-clinical studies.
  • Notably, it has shown the ability to disrupt the destructive cycle of binge drinking without inducing hallucinations—a common concern with existing treatments.
  • The journey ahead is filled with potential, and we eagerly anticipate sharing impactful updates with our shareholders."

The Canadian Centre on Substance Use and Addiction Welcomes Scott Elliott to its Board of Directors

Retrieved on: 
Monday, April 8, 2024
Addiction, Mental health, Chair, Substance, HIV, Knowledge, The Honourable, Research, Health Canada, Parliament, DSM-IV codes, CCSA

“Scott is known for his efforts in tackling substance use health issues and finding unique, powerful solutions.

Key Points: 
  • “Scott is known for his efforts in tackling substance use health issues and finding unique, powerful solutions.
  • Mr. Elliott is the Chief Executive Officer of the Dr. Peter Centre in Vancouver, B.C.
  • The Centre provides clinical, social and psychological support to marginalized community members living with HIV, complex medical conditions, mental illness, and substance use and addictions.
  • “People in Canada will benefit from Scott’s understanding of community building and the diverse experiences across substance use health.”
    Mr. Elliott joins 12 other directors to complete CCSA’s volunteer Board of Directors.

Partnership for a Drug-Free New Jersey’s Opioid Prevention Initiatives Recognized at National Rx Summit

Retrieved on: 
Thursday, April 4, 2024
Prohibition, Mental health, Organization, Communication, Partnership, COVID-19, Patient, Knowledge, Human services, Volunteering, Advertising, Substance use disorder, Addiction, Poster, Government, Knockout, Cryptocurrency

PDFNJ highlighted these initiatives, which are critical in providing New Jersey communities with vital information on preventing opioid misuse, as part of the Rx Summit’s poster sessions.

Key Points: 
  • PDFNJ highlighted these initiatives, which are critical in providing New Jersey communities with vital information on preventing opioid misuse, as part of the Rx Summit’s poster sessions.
  • Through this program, more than 10,000 volunteers throughout the state share opioid prevention and awareness messages and materials.
  • “At the Rx Summit, we shared our strategies for reaching New Jersey communities with essential information on preventing opioid misuse,” said Angelo Valente, Executive Director of PDFNJ.
  • Since its inception, the Partnership has garnered 226 advertising and public relations awards from national, regional and statewide media organizations.

Inspiring Hope Together: Canadian Association for Suicide Prevention Announces National Suicide Prevention Conference in Vancouver, BC

Retrieved on: 
Thursday, April 4, 2024
SDP, Mental health, Conference, Communication, CASP, LivingWorks, CAMH, Suicide, Death, Addiction, Root, Nursing

VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- The Canadian Association for Suicide Prevention (CASP) is thrilled to announce the "Inspiring Hope Together" National Suicide Prevention Conference, scheduled to take place from May 29 to May 31, 2024, at the prestigious Pinnacle Hotel Harbourfront in Vancouver, BC.

Key Points: 
  • VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- The Canadian Association for Suicide Prevention (CASP) is thrilled to announce the "Inspiring Hope Together" National Suicide Prevention Conference, scheduled to take place from May 29 to May 31, 2024, at the prestigious Pinnacle Hotel Harbourfront in Vancouver, BC.
  • The theme of the conference, “Inspiring Hope Together,” emphasizes the transformative power of unity and the collective strength necessary to effect positive change in our communities.
  • Join us as we Inspire Hope Together and chart a course towards a brighter future in suicide prevention.
  • With support from Inspiring Hope Ally Sponsors, LivingWorks, Mental Health Commission of Canada (MHCC), Services de Développement Professionnels (SDP), and Roots of Hope, the National Suicide Prevention Conference is the premiere Canadian event for exchanging knowledge on suicide prevention, intervention, postvention, and life promotion, not to be missed!

Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update

Retrieved on: 
Tuesday, April 2, 2024
Research, Frost, Patent, Partnership, Patient, OUD, G&A, Opioid use disorder, Addiction, GLEN, Consultant, Pharmaceutical industry

GLEN ALLEN, Va., April 02, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the 2023 fiscal year ended December 31, 2023.

Key Points: 
  • GLEN ALLEN, Va., April 02, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the 2023 fiscal year ended December 31, 2023.
  • Specifically, we conducted meetings and received favorable feedback from both US and European regulators, allowing us to refine our clinical development plan.
  • Cash and cash equivalents were $2.8 million as of December 31, 2023, compared to $4.0 million as of December 31, 2022.
  • Net Loss was $5.1 million for the year ended December 31, 2023, compared to a net loss of $12.7 million for the year ended December 31, 2022.

Virtue Recovery Chandler Launches Comprehensive Program for Long-Term Sobriety

Retrieved on: 
Monday, April 8, 2024
Healing, Physical fitness, Aftercare, Addiction, Hope

CHANDLER, Ariz., April 8, 2024 /PRNewswire-PRWeb/ -- Virtue Recovery Center, a leading name in addiction treatment in Chandler, Arizona, has announced the launch of its groundbreaking program aimed at providing comprehensive support for individuals seeking long-term sobriety. This innovative initiative addresses the multifaceted nature of addiction, offering a path to recovery as personalized as the stories of the individuals it aims to help.

Key Points: 
  • Virtue Recovery Center, a leading name in addiction treatment in Chandler, Arizona, has announced the launch of its groundbreaking program aimed at providing comprehensive support for individuals seeking long-term sobriety.
  • CHANDLER, Ariz., April 8, 2024 /PRNewswire-PRWeb/ -- Virtue Recovery Center, a leading name in addiction treatment in Chandler, Arizona, has announced the launch of its groundbreaking program aimed at providing comprehensive support for individuals seeking long-term sobriety.
  • At the heart of Virtue Recovery Chandler is the conviction that the journey to overcome addiction is as individual as the people who embark on it.
  • The launch of Virtue Recovery's comprehensive program for long-term sobriety marks a significant step forward in the fight against addiction.

TMS Health and Wellness Introduces Cutting-Edge Brain Scanning For Enhanced TMS Therapy Effectiveness

Retrieved on: 
Monday, April 8, 2024
Depression, Mindfulness, Magnetic resonance, Medicine, Health, Neuroimaging, Patient, TMS, Anxiety, Addiction, Chronic pain, Functional, Concierge medicine, Meditation, Wellness, Transcranial magnetic stimulation, Homeopathy, Neurofeedback, Map, Medical imaging

COSTA MESA, Calif., April 8, 2024 /PRNewswire-PRWeb/ -- In a significant advancement for treating anxiety, depression, and other mental health conditions, TMS Health and Wellness proudly announces the integration of comprehensive brain scanning technology into its Transcranial Magnetic Stimulation (TMS) Therapy protocols. This pioneering approach, leveraging Full Brain Scans and Functional MRI (fMRI) is set to revolutionize treatment customization, potentially elevating TMS Therapy's effectiveness to an unprecedented 90%.

Key Points: 
  • This pioneering approach, leveraging Full Brain Scans and Functional MRI (fMRI) is set to revolutionize treatment customization, potentially elevating TMS Therapy's effectiveness to an unprecedented 90%.
  • By utilizing detailed brain imaging to map and understand each patient's unique neural patterns, TMS Health and Wellness can customize the application of TMS Therapy with greater precision than ever before.
  • The clinic's expanded services now include:
    With the introduction of brain scanning technology, TMS Health and Wellness reinforces its dedication to pioneering in the mental health space and its mission of treating the "whole person."
  • TMS Therapy enhanced with Full Brain Scans and Functional MRI is available now.

Government of Canada announces support for innovative solutions to address labour challenges in the agriculture and agri-food sector

Retrieved on: 
Friday, April 5, 2024
Automation, ICS, Parliament, Addiction, Mental health, Farmer, Growth, Learning, Social change, Food safety, The Honourable, Controlled-environment agriculture, Human, Plant, Robotics, ISC, Invention, Safety, Food, CEA, SME, Government, Movement

These companies have developed ideas to address challenges such as work productivity, labour shortages, and operational efficiency.

Key Points: 
  • These companies have developed ideas to address challenges such as work productivity, labour shortages, and operational efficiency.
  • -       The Honourable Lawrence MacAulay, Minister of Agriculture and Agri-Food
    "Through the Innovative Solutions Canada program, our government empowers SMEs to drive innovation and solve challenges.
  • Our government supports these efforts through Innovative Solutions Canada, assisting small and medium-sized Canadian businesses in developing new inventions that are crucial for the sector.
  • We are grateful to the Innovative Solutions Canada Program and Agriculture and Agri-Food Canada for their support to develop a market ready solution which we can pioneer in Canada."

Infectious Disease Specialist Calls Campaign against Repurposed Drugs in COVID-19 a ‘Great Hypocrisy’

Retrieved on: 
Thursday, March 21, 2024
Vanderbilt University, COVID, HCQ, Rheumatoid arthritis, Infection, Azithromycin, Lupus, Diabetes, COVID-19, Patient, Knowledge, Journal, Mortality, Addiction, Hydroxychloroquine, AAPS, Dysautonomia, Physician, Ivermectin, IVM, Pharmaceutical industry

Just before the death-knell announcement, Dr. Hoffman notes, substantial evidence favoring early use of HCQ had been submitted for publication by Dr. Harvey Risch of Yale.

Key Points: 
  • Just before the death-knell announcement, Dr. Hoffman notes, substantial evidence favoring early use of HCQ had been submitted for publication by Dr. Harvey Risch of Yale.
  • “In fact, all evidence is inherently flawed.”
    Dr. Hoffman points out how inconsistencies and double standards reveal the FDA’s hypocrisy regarding HCQ and ivermectin (IVM).
  • Paxlovid, he writes, has not been shown to be effective in hospitalized COVID patients, whereas the “flawed” study of HCQ demonstrated a greater than 60 percent benefit in reducing mortality.
  • “There is in fact a corpus of knowledge about the use of HCQ, IVM, and other off-label drugs, for example, at c19hcq.org, c19IVM.org18, and earlycovidcare.org,” Dr. Hoffman states.